EUVIMEDEUVIMED entdecken
Crossref

The burgeoning liver disease at the interface of metabolic syndrome and type 2 diabetes: Nonalcoholic fatty liver disease (NAFLD)

Shakil A Saghir, Dileep K Rohra, Riyadh S. Almalki, Rais Ansari

Archives of Clinical Toxicology · 2024

DOI: 10.46439/toxicology.6.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Clinical Toxicology, 2024. Verfasst von Shakil A Saghir und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Saghir, S. A., Rohra, D. K., Almalki, R. S., & Ansari, R. (2024). The burgeoning liver disease at the interface of metabolic syndrome and type 2 diabetes: Nonalcoholic fatty liver disease (NAFLD). Archives of Clinical Toxicology. https://doi.org/10.46439/toxicology.6.028

Vancouver

Saghir SA, Rohra DK, Almalki RS, Ansari R. The burgeoning liver disease at the interface of metabolic syndrome and type 2 diabetes: Nonalcoholic fatty liver disease (NAFLD). Archives of Clinical Toxicology. 2024. doi:10.46439/toxicology.6.028

BibTeX
@article{Saghir2024,
  author = {Saghir, Shakil A and Rohra, Dileep K and Almalki, Riyadh S. and Ansari, Rais},
  title = {The burgeoning liver disease at the interface of metabolic syndrome and type 2 diabetes: Nonalcoholic fatty liver disease (NAFLD)},
  journal = {Archives of Clinical Toxicology},
  year = {2024},
  doi = {10.46439/toxicology.6.028}
}
Kostenlos starten →